Cost-effectiveness of methotrexate and Goeckerman therapy: A flawed analysis [5] (multiple letters)

Archives of Dermatology

Volumn 135, Issue 6, 1999, Pages 717-718

  Lim, H W ^a   Anderson, T F ^a   Douglass, M ^a   Koo, J ^a   Lebwohl, M ^a   Morison, W ^a   Taylor, C ^a   Zanolli, M ^a   Chen, S ^a   Garber, A M ^a  

^a HENRY FORD HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METHOTREXATE;

COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; COST OF ILLNESS; DRUG COST; DRUG INDICATION; DRUG SAFETY; HUMAN; LETTER; LIVER TOXICITY; PRIORITY JOURNAL; PSORIASIS;

COST-BENEFIT ANALYSIS; DERMATOLOGIC AGENTS; HUMANS; METHOTREXATE; PSORIASIS; ULTRAVIOLET THERAPY;

EID: 0033026749     PISSN: 0003987X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archderm.135.6.717     Document Type: Letter

References (0)